1. |
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part I: diagnosis and classification of diabetes mellitus. Provisional Report of WHD Consultation. Diabet Med, 1998, 15: 539-553.
|
2. |
Nosadini R, Velussi M, Brocco E, et al. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenic mechanisms. Diabetes, 2005, 54: 228-233.
|
3. |
Benigni A, Gagliardini E, Tomasoni S, et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int, 2004, 65: 2193-2200.
|
4. |
Ceol M, Gambaro G, Sauer U, et al. Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats. J Am Soc Nephrol, 2000, 11: 2324-2336.
|
5. |
Gambaro G, Kinalska I, Oksa A, et al. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial. J Am Soc Nephrol, 2002, 13: 1615-1625.
|
6. |
Parving HH, Chaturvedi N, Viberti G, et al. Does microalbuminuria predict diabetic nephropathy? Diabetes Care, 2002, 25: 406-407.
|
7. |
Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24: 683-689.
|
8. |
Hostetter TH. Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med, 2001, 345: 910-912.
|